Minimum Residual Disease in Acute Lymphoblastic Leukemia
5 Tampilan
• 08/04/23
0
0
Menanamkan
administrator
Pelanggan
In this segment, Jeffrey Lancet, MD; Raoul Tibes, MD; and Mark R. Litzow, MD, describe various methodologies in monitoring minimum residual disease in acute lymphoblastic leukemia.
Menampilkan lebih banyak
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru